Year archive

GlaxoSmithKline PLC — 2026 filings

All 229 regulatory filings released by GlaxoSmithKline PLC (GSK) in 2026, sourced directly from the official regulator.

229 Filings

2026 Period

2026 filings (229)

Filing	Released	Lang
Director/PDMR Shareholding Director's Dealing	2026-05-14	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2026-05-14	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-05-11	English
Director/PDMR Shareholding Director's Dealing	2026-05-11	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-05-11	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-05-11	English
Collaboration with CTTQ for bepirovirsen Regulatory Filings	2026-05-11	English
GSK - final tranche of share buyback programme Transaction in Own Shares	2026-05-11	English
2026 AGM Resolutions Regulatory Filings	2026-05-07	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-05-06	English
Result of AGM AGM Information	2026-05-06	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-05-05	English
Director/PDMR Shareholding Director's Dealing	2026-05-05	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-05-01	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-05-01	English
Holding(s) in Company Regulatory Filings	2026-05-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2026-05-01	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-29	English
Director/PDMR Shareholding Director's Dealing	2026-04-29	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-29	English
1st Quarter Results Earnings Release Q1 2026	2026-04-29	English
Annual Financial Report Report Publication Announcement	2026-04-28	English
Annual Financial Report Annual Report FY 2025	2026-04-28	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-28	English
Director/PDMR Shareholding Director's Dealing	2026-04-28	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-28	English
Bepirovirsen priority review US filing acceptance Regulatory Filings	2026-04-28	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-27	English
Efimosfermin granted US/EU regulatory designations Regulatory Filings	2026-04-27	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-27	English
TESARO update on AnaptysBio Inc. litigation Legal Proceedings Report	2026-04-27	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-24	English
Director/PDMR Shareholding Director's Dealing	2026-04-24	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-23	English
Transaction in Own Shares Transaction in Own Shares	2026-04-23	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-22	English
Transaction in Own Shares Transaction in Own Shares	2026-04-22	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-21	English
Transaction in Own Shares Transaction in Own Shares	2026-04-21	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-20	English
Director/PDMR Shareholding Director's Dealing	2026-04-20	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-20	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-20	English
Blenrep approved in China for 2L+ multiple myeloma Regulatory Filings	2026-04-20	English
Transaction in Own Shares Transaction in Own Shares	2026-04-20	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-17	English
Transaction in Own Shares Transaction in Own Shares	2026-04-17	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-16	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-16	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-15	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-15	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-14	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-14	English
Transaction in Own Shares Transaction in Own Shares	2026-04-14	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-13	English
Director/PDMR Shareholding Director's Dealing	2026-04-13	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-13	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-13	English
Transaction in Own Shares Transaction in Own Shares	2026-04-13	English
GSK presents positive data for BEHOLD 1 B7 H4 ADC Regulatory Filings	2026-04-13	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-10	English
Director/PDMR Shareholding Director's Dealing	2026-04-10	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-10	English
Transaction in Own Shares Transaction in Own Shares	2026-04-10	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-09	English
Director/PDMR Shareholding Director's Dealing	2026-04-09	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-09	English
Transaction in Own Shares Transaction in Own Shares	2026-04-09	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-08	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-08	English
Exdensur approved for CRSwNP in China Regulatory Filings	2026-04-08	English
Transaction in Own Shares Transaction in Own Shares	2026-04-08	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-07	English
Transaction in Own Shares Transaction in Own Shares	2026-04-07	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-02	English
Transaction in Own Shares Transaction in Own Shares	2026-04-02	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-01	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-01	English
Director/PDMR Shareholding Director's Dealing	2026-04-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2026-04-01	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-01	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-04-01	English
ViiV completes changes to minority shareholding Share Issue/Capital Change	2026-04-01	English
Transaction in Own Shares Transaction in Own Shares	2026-04-01	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-03-31	English
Transaction in Own Shares Transaction in Own Shares	2026-03-31	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-03-30	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-03-30	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-03-30	English
Bepirovirsen accepted for review in China Regulatory Filings	2026-03-30	English
Exdensur approved for severe asthma in China Regulatory Filings	2026-03-30	English
Transaction in Own Shares Transaction in Own Shares	2026-03-30	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-03-27	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-03-27	English
Bepirovirsen accepted for review by the EMA Regulatory Filings	2026-03-27	English
Transaction in Own Shares Transaction in Own Shares	2026-03-27	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-03-26	English
Transaction in Own Shares Transaction in Own Shares	2026-03-26	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-03-25	English
Director/PDMR Shareholding Director's Dealing	2026-03-25	English
Articles of Association - Proposed Amendments Governance Information	2026-03-25	English
GSK Proxy Form 2026 Proxy Solicitation & Information Statement	2026-03-25	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-03-25	English
GSK Notice of AGM 2026 Proxy Solicitation & Information Statement	2026-03-25	English
Notice of AGM Proxy Solicitation & Information Statement	2026-03-25	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-03-25	English
Transaction in Own Shares Transaction in Own Shares	2026-03-25	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-03-24	English
Transaction in Own Shares Transaction in Own Shares	2026-03-24	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-03-23	English
Director/PDMR Shareholding Director's Dealing	2026-03-23	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-03-23	English
Admission to Trading Share Issue/Capital Change	2026-03-23	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-03-23	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-03-23	English
GSK Lung Cancer ADC Gets Japan Orphan Drug Status Regulatory Filings	2026-03-23	English
Transaction in Own Shares Transaction in Own Shares	2026-03-23	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-03-20	English
Transaction in Own Shares Transaction in Own Shares	2026-03-20	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-03-19	English
Lynavoy (linerixibat) approved by US FDA Regulatory Filings	2026-03-19	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-03-19	English
Transaction in Own Shares Transaction in Own Shares	2026-03-19	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-03-18	English
Director/PDMR Shareholding Director's Dealing	2026-03-18	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-03-18	English
Transaction in Own Shares Transaction in Own Shares	2026-03-18	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-03-17	English
Director/PDMR Shareholding Director's Dealing	2026-03-17	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-03-17	English
Transaction in Own Shares Transaction in Own Shares	2026-03-17	English
Transaction in Own Shares Transaction in Own Shares	2026-03-16	English
US FDA approves Arexvy for adults 18-49 AIR Regulatory Filings	2026-03-13	English
Transaction in Own Shares Transaction in Own Shares	2026-03-13	English
Director/PDMR Shareholding Director's Dealing	2026-03-12	English
Transaction in Own Shares Transaction in Own Shares	2026-03-12	English
Transaction in Own Shares Transaction in Own Shares	2026-03-11	English
Transaction in Own Shares Transaction in Own Shares	2026-03-10	English
Board Committee Change Board/Management Information	2026-03-09	English
GSK and Alfasigma agree global linerixibat rights M&A Activity	2026-03-09	English
Transaction in Own Shares Transaction in Own Shares	2026-03-09	English
Filing of GSK plc 2025 Annual Report on Form 20-F Report Publication Announcement	2026-03-06	English
Transaction in Own Shares Transaction in Own Shares	2026-03-06	English
GSK publishes Annual Report 2025 Annual Report	2026-03-05	English
2025 Annual Financial Report Annual Report (ESEF)	2026-03-05	English
2025 Annual Financial Report Annual Report	2026-03-05	English
Transaction in Own Shares Transaction in Own Shares	2026-03-05	English
Director/PDMR Shareholding Director's Dealing	2026-03-04	English
Transaction in Own Shares Transaction in Own Shares	2026-03-04	English
GSK completes acquisition of RAPT Therapeutics M&A Activity	2026-03-03	English
Transaction in Own Shares Transaction in Own Shares	2026-03-03	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2026-03-02	English
Transaction in Own Shares Transaction in Own Shares	2026-03-02	English
Director/PDMR Shareholding Director's Dealing	2026-02-27	English
Transaction in Own Shares Transaction in Own Shares	2026-02-27	English
Linerixibat accepted for priority review in China Regulatory Filings	2026-02-26	English
Bepirovirsen accepted for Japan regulatory review Regulatory Filings	2026-02-26	English
Transaction in Own Shares Transaction in Own Shares	2026-02-26	English
Director/PDMR Shareholding Director's Dealing	2026-02-25	English
Director/PDMR Shareholding Director's Dealing	2026-02-25	English
GSK enters agreement to acquire 35Pharma M&A Activity	2026-02-25	English
Transaction in Own Shares Transaction in Own Shares	2026-02-25	English
Director/PDMR Shareholding Director's Dealing	2026-02-24	English
Transaction in Own Shares Transaction in Own Shares	2026-02-24	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-02-23	English
Transaction in Own Shares Transaction in Own Shares	2026-02-23	English
6-K - GSK plc (0001131399) (Filer) Foreign Filer Report	2026-02-20	English
Director/PDMR Shareholding Director's Dealing	2026-02-20	English
Transaction in Own Shares Transaction in Own Shares	2026-02-20	English
Director/PDMR Shareholding Director's Dealing	2026-02-19	English
Transaction in Own Shares Transaction in Own Shares	2026-02-19	English
Transaction in Own Shares Transaction in Own Shares	2026-02-18	English
Director/PDMR Shareholding Director's Dealing	2026-02-17	English
Director/PDMR Shareholding Director's Dealing	2026-02-17	English
GSK - fourth tranche of share buyback programme Transaction in Own Shares	2026-02-17	English
Exdensur approved by the European Commission Regulatory Filings	2026-02-17	English
Director/PDMR Shareholding Director's Dealing	2026-02-16	English
Director/PDMR Shareholding Director's Dealing	2026-02-16	English
Director/PDMR Shareholding Director's Dealing	2026-02-16	English
13F-HR Filing Regulatory Filings	2026-02-12	English
Director/PDMR Shareholding Director's Dealing	2026-02-11	English
Director/PDMR Shareholding Director's Dealing	2026-02-11	English
Director/PDMR Shareholding Director's Dealing	2026-02-11	English
Director/PDMR Shareholding Director's Dealing	2026-02-11	English
6-K Filing Foreign Filer Report	2026-02-11	English
6-K Filing Foreign Filer Report	2026-02-11	English
6-K Filing Foreign Filer Report	2026-02-11	English
6-K Filing Foreign Filer Report	2026-02-11	English
China CDE accepts Arexvy adults 60+ application Regulatory Filings	2026-02-10	English
6-K Filing Foreign Filer Report	2026-02-10	English
Director/PDMR Shareholding Director's Dealing	2026-02-09	English
6-K Filing Foreign Filer Report	2026-02-09	English
Director/PDMR Shareholding Director's Dealing	2026-02-06	English
Nucala COPD approved by the European Commission Regulatory Filings	2026-02-06	English
6-K Filing Foreign Filer Report	2026-02-06	English
6-K Filing Foreign Filer Report	2026-02-06	English
Director/PDMR Shareholding Director's Dealing	2026-02-05	English
6-K Filing Foreign Filer Report	2026-02-05	English
Final Results Earnings Release FY 2025	2026-02-04	English
6-K Filing Foreign Filer Report	2026-02-04	English
Total Voting Rights Regulatory Filings	2026-02-02	English
SC TO-T Filing Regulatory Filings	2026-02-02	English
6-K Filing Foreign Filer Report	2026-02-02	English
European Commission approves Arexvy for adults 18+ Regulatory Filings	2026-01-26	English
6-K Filing Foreign Filer Report	2026-01-26	English
GSK to acquire RAPT Therapeutics M&A Activity	2026-01-20	English
Agreement on changes to ViiV minority shareholding Share Issue/Capital Change	2026-01-20	English
6-K Filing Foreign Filer Report	2026-01-20	English
SC TO-C Filing Regulatory Filings	2026-01-20	English
SC TO-C Filing Regulatory Filings	2026-01-20	English
6-K Filing Foreign Filer Report	2026-01-20	English
Director/PDMR Shareholding Director's Dealing	2026-01-16	English
6-K Filing Foreign Filer Report	2026-01-16	English
Director/PDMR Shareholding Director's Dealing	2026-01-15	English
6-K Filing Foreign Filer Report	2026-01-15	English
Director/PDMR Shareholding Director's Dealing	2026-01-13	English
6-K Filing Foreign Filer Report	2026-01-13	English
EC approval of Shingrix PFS Regulatory Filings	2026-01-07	English
Positive phase 3 data for GSK's bepirovirsen Regulatory Filings	2026-01-07	English
6-K Filing Foreign Filer Report	2026-01-07	English
6-K Filing Foreign Filer Report	2026-01-07	English
Exdensur approved in Japan Regulatory Filings	2026-01-06	English
6-K Filing Foreign Filer Report	2026-01-06	English
Director/PDMR Shareholding Director's Dealing	2026-01-05	English
Total Voting Rights Regulatory Filings	2026-01-05	English
Nucala for adults with COPD approved in China Regulatory Filings	2026-01-05	English
6-K Filing Foreign Filer Report	2026-01-05	English
6-K Filing Foreign Filer Report	2026-01-05	English
6-K Filing Foreign Filer Report	2026-01-05	English

Filings by year

2026 229 filings
2025 709 filings
2024 332 filings
2023 304 filings
2022 416 filings
2021 350 filings
2020 337 filings
2019 337 filings
2018 352 filings
2017 355 filings
2016 527 filings
2015 397 filings
2014 569 filings
2013 727 filings
2012 472 filings
2011 400 filings
2010 157 filings
2009 1 filing